Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Clomipramine 25mg/2ml solution for injection ampoules
0403010F0AAADAD
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Clomipramine 25mg/5ml oral liquid
0403010F0AAAKAK
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Clomipramine 37.5mg/5ml oral liquid
0403010F0AAAPAP
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Clomipramine 50mg/5ml oral solution
0403010F0AAANAN
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Clomipramine 5mg/5ml oral liquid
0403010F0AAAMAM
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Clonazepam 1.25mg/5ml oral liquid
0408010F0AABFBF
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 1.2mg/5ml oral liquid
0408010F0AACXCX
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 1.5mg/5ml oral liquid
0408010F0AABKBK
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 100micrograms/5ml oral liquid
0408010F0AACFCF
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 10mg/5ml oral liquid
0408010F0AACSCS
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 12.5mg/5ml oral liquid
0408010F0AACACA
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 120micrograms/5ml oral liquid
0408010F0AABJBJ
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 150micrograms/5ml oral liquid
0408010F0AACHCH
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 160micrograms/5ml oral liquid
0408010F0AACNCN
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 180micrograms/5ml oral liquid
0408010F0AACVCV
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 1mg/5ml oral liquid
0408010F0AABGBG
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 2.5mg/5ml oral liquid
0408010F0AABPBP
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 2.5mg/ml drops sugar free
0408010F0AAAAAA
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 200micrograms/5ml oral liquid
0408010F0AABHBH
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 25mg/5ml oral liquid
0408010F0AACLCL
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 25micrograms/5ml oral liquid
0408010F0AACCCC
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 3.75mg/5ml oral liquid
0408010F0AABRBR
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 300micrograms/5ml oral liquid
0408010F0AACGCG
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 312.5micrograms/5ml oral liquid
0408010F0AABWBW
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
|
Clonazepam 330micrograms/5ml oral liquid
0408010F0AACUCU
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.